InMode (INMD) Net Cash Flow (QoQ) (2018 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn |
| 10 | InMode | 3.41 | -384.57 Mn | 61.55 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 84.00% |
| Dec 31, 2025 | 37.52% |
| Sep 30, 2025 | -47.08% |
| Jun 30, 2025 | 791.85% |
| Mar 31, 2025 | -21.61% |
| Dec 31, 2024 | -111.33% |
| Sep 30, 2024 | 350.38% |
| Jun 30, 2024 | -24.99% |
| Mar 31, 2024 | -333.91% |
| Dec 31, 2023 | 138.41% |
| Sep 30, 2023 | -138.38% |
| Jun 30, 2023 | 1,501.13% |
| Mar 31, 2023 | -124.44% |
| Dec 31, 2022 | 295.32% |
| Sep 30, 2022 | -122.30% |
| Jun 30, 2022 | 292.20% |
| Mar 31, 2022 | -2,750.24% |
| Dec 31, 2021 | -110.86% |
| Sep 30, 2021 | 339.64% |
| Jun 30, 2021 | 17.59% |
| Mar 31, 2021 | -689.65% |
| Dec 31, 2020 | -112.60% |
| Sep 30, 2020 | -80.32% |
| Jun 30, 2020 | 2,925.31% |
| Mar 31, 2020 | 115.66% |
| Dec 31, 2019 | -120.65% |
| Sep 30, 2019 | 100.84% |
| Jun 30, 2019 | 271.02% |
| Mar 31, 2019 | -239.46% |
| Dec 31, 2018 | 133.68% |
| Sep 30, 2018 | -223.87% |